Syncona (LON:SYNC) Trading Up 2.2% - Still a Buy?

Key Points

• Syncona's stock price rose by 2.2% on Monday, closing at GBX 97.30 ($1.31) despite a significant decline in trading volume.
• The company has a market cap of £605.63 million and a negative PE ratio of -35.88.
• Syncona focuses on investing in and developing life science businesses to deliver transformative treatments, targeting areas of high unmet need.

Syncona (LON:SYNC - )'s stock price was up 2.2% during trading on Monday . The company traded as high as GBX 97.30 ($1.31) and last traded at GBX 97.30 ($1.31). Approximately 211,452 shares changed hands during trading, a decline of 70% from the average daily volume of 715,410 shares. The stock had previously closed at GBX 95.20 ($1.28).

Syncona Price Performance

The stock's 50-day moving average is GBX 95.06 and its 200 day moving average is GBX 91. The company has a market cap of £605.63 million, a PE ratio of -35.88 and a beta of 0.26.

About Syncona

Syncona's purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.